中国P站

Immunometabolism; Immune Cell Metabolism; Mitochondrial Function; Gut Microbiome; Cancer Metabolism; Macrophage Polarization; T Cell Differentiation; Autophagy; Inflammation; Dietary Interventions

Introduction

Immunometabolism represents a rapidly evolving interdisciplinary field that investigates the complex interplay between immune cell functionality and the metabolic processes that govern them. This area of research underscores how fundamental metabolic pathways, including glycolysis and oxidative phosphorylation, undergo significant reprogramming to provide the necessary energy and building blocks for robust immune responses. These metabolic adaptations are not merely passive consequences of immune activation but are active drivers of critical immune processes such as T cell differentiation into various effector or memory subtypes, the polarization of macrophages into distinct functional states (e.g., pro-inflammatory M1 or anti-inflammatory M2), and the intricate signaling cascades that orchestrate inflammation throughout the body. A profound understanding of these metabolic shifts is therefore paramount for the rational design and development of novel immunotherapeutic strategies aimed at treating a wide spectrum of diseases, ranging from infectious agents to autoimmune disorders and cancer [1].

Mitochondrial dynamics and the overall functional integrity of these crucial organelles are emerging as central determinants of immune cell activation and their capacity to execute effector functions effectively. Evidence suggests that disruptions or dysfunctions within the mitochondrial network can lead to a compromised immune system, characterized by impaired responses to pathogens and an exacerbation of chronic inflammatory conditions. Within this context, cellular quality control mechanisms, such as mitophagy—the selective degradation of damaged mitochondria—are recognized as essential for preserving immune homeostasis and preventing the pathological accumulation of dysfunctional organelles that could otherwise fuel aberrant immune signaling [2].

The intricate ecosystem of the gut microbiome exerts a substantial and multifaceted influence on the host's immune system, largely mediated through the metabolic products generated by microbial communities. These metabolites can traverse the intestinal barrier and interact with immune cells, thereby modulating their development, activation, and overall functional output. Among the most well-studied of these microbial metabolites are short-chain fatty acids (SCFAs), which are produced via the fermentation of dietary fiber by resident gut bacteria. SCFAs have been demonstrated to play a critical role in regulating T cell differentiation, particularly promoting the development of regulatory T cells (Tregs), and are essential for maintaining intestinal immune tolerance, a state that prevents the immune system from mounting damaging responses against commensal microbes or dietary antigens [3].

Metabolic reprogramming within cancer cells is a defining characteristic that enables their relentless proliferation and allows them to evade immune surveillance. Tumor cells often hijack host metabolic pathways to satisfy their high energy demands and to generate the molecular intermediates required for rapid growth and division. Crucially, this metabolic plasticity also contributes to the creation of an immunosuppressive tumor microenvironment. Consequently, targeting these specific metabolic vulnerabilities present in cancer cells represents a highly promising therapeutic avenue, potentially through strategies that can re-sensitize tumors to the host's immune system or directly inhibit tumor growth by starving them of essential metabolic resources [4].

Maintaining a delicate and tightly controlled balance between pro-inflammatory and anti-inflammatory immune responses is a fundamental requirement for health, and this equilibrium is significantly influenced by metabolic cues. For instance, activated macrophages, key players in innate and adaptive immunity, can adopt distinct metabolic profiles that directly dictate their polarization state and the types and quantities of cytokines they produce. This metabolic flexibility allows macrophages to tailor their responses to specific environmental signals, thereby profoundly impacting disease progression in diverse inflammatory contexts [5].

The metabolic state of T cells undergoes dramatic transformations during their activation and differentiation, dictating their ultimate functional fate. Naive T cells, which have not yet encountered antigen, primarily rely on oxidative phosphorylation for their metabolic needs, emphasizing their requirement for sustained energy production for survival. In contrast, upon activation, effector T cells undergo a significant metabolic shift, preferentially utilizing aerobic glycolysis. This metabolic reprogramming is essential to meet the exceptionally high energetic and biosynthetic demands associated with rapid proliferation and the production of effector molecules necessary for mounting a potent adaptive immune response against pathogens or transformed cells [6].

Pathogens have evolved sophisticated mechanisms to manipulate the host cell's metabolic landscape, often co-opting cellular metabolic pathways to facilitate their own survival, replication, and dissemination. This manipulation can involve diverting host metabolites, altering host metabolic enzyme activity, or influencing host metabolic signaling pathways to create an environment conducive to pathogen growth. A thorough understanding of these intricate host-pathogen metabolic interactions is therefore indispensable for the development of effective and novel anti-infective strategies that can disrupt pathogen reliance on host metabolism [7].

Metabolic enzymes are increasingly being recognized not just as catalysts for biochemical reactions but as critical regulators of inflammatory pathways. Beyond their canonical roles in energy production and biosynthesis, certain metabolic intermediates and even the enzymes themselves can directly interact with and modulate the activity of key signaling molecules and cascades that orchestrate the inflammatory response. This direct regulatory capacity highlights metabolic enzymes as attractive and potentially novel therapeutic targets for the management of inflammatory diseases [8].

Autophagy, a fundamental cellular process responsible for the degradation and recycling of damaged organelles and misfolded proteins, is intrinsically linked to cellular metabolism and plays a vital role in the proper functioning and survival of immune cells. This cellular housekeeping mechanism is crucial for maintaining immune homeostasis by clearing cellular debris and providing essential building blocks during times of metabolic stress. Dysregulation of autophagy can lead to the accumulation of toxic cellular components, immune cell dysfunction, and the promotion of chronic inflammatory diseases, underscoring its importance in immune health [9].

Dietary interventions represent a powerful and accessible means to modulate the complex field of immunometabolism. By altering the availability of essential nutrients and influencing the composition and metabolic activity of the gut microbiota, dietary changes can profoundly impact immune cell function and inflammatory tone. This recognition opens up exciting possibilities for leveraging nutritional strategies not only to enhance immune responses against pathogens but also to treat a wide array of metabolic and inflammatory diseases by rebalancing immune and metabolic circuits through targeted nutrition [10].

Description

Immunometabolism is a burgeoning field dedicated to unraveling the intricate connections between immune cell function and the metabolic machinery that underpins it. It elucidates how key metabolic pathways, such as glycolysis and oxidative phosphorylation, are actively remodeled to support the energetic and biosynthetic requirements of immune responses. This metabolic plasticity is fundamental to diverse immunological processes, including the differentiation of T cells into specialized subsets, the polarization of macrophages into distinct functional phenotypes that dictate their inflammatory roles, and the complex signaling networks that govern inflammation across tissues. A deep comprehension of these metabolic adaptations is therefore indispensable for the innovation of novel immunotherapeutic approaches to combat a wide range of diseases [1].

Mitochondrial dynamics, encompassing their formation, fission, fusion, and degradation, alongside their overall functional integrity, are critical determinants of immune cell activation and the execution of effector functions. Impairments in mitochondrial health or dynamics can lead to suboptimal immune cell performance and contribute to the pathogenesis of chronic inflammatory disorders. The cellular machinery responsible for maintaining mitochondrial quality, particularly the process of mitophagy, is essential for preserving immune homeostasis and ensuring that immune cells can respond effectively to challenges [2].

The gut microbiome exerts a profound influence on host immunity, significantly shaping immune cell development and function through the metabolic byproducts it generates. These microbial metabolites can enter systemic circulation or interact locally within the gut, modulating immune responses. Among these, short-chain fatty acids (SCFAs), derived from the bacterial fermentation of dietary fibers, have emerged as key players. They critically regulate T cell differentiation, promoting the development of immune-suppressive regulatory T cells, and are vital for establishing and maintaining intestinal immune tolerance, thereby preventing aberrant immune reactions to harmless antigens [3].

Metabolic reprogramming within cancer cells is a hallmark that fuels their uncontrolled proliferation and facilitates their escape from immune surveillance. Cancer cells often exhibit altered metabolic dependencies that are exploited to meet their high energy and biosynthetic needs. Understanding these metabolic vulnerabilities is crucial, as targeting them offers a promising avenue for cancer therapy. Such strategies may aim to starve tumor cells of essential nutrients, disrupt their metabolic pathways, or render them more susceptible to immune-mediated destruction, thereby potentially enhancing the efficacy of immunotherapies [4].

The orchestration of pro-inflammatory and anti-inflammatory immune responses is precisely regulated by metabolic cues. Activated macrophages, for example, exhibit remarkable metabolic flexibility, adopting distinct metabolic profiles that directly influence their polarization status and the release of cytokines. This metabolic control is pivotal in determining whether macrophages promote or resolve inflammation, profoundly impacting the course of various diseases and the overall inflammatory tone of the host [5].

Naive T cells primarily depend on oxidative phosphorylation for their metabolic needs, supporting their long-term survival. Upon activation, however, T cells undergo a significant metabolic shift, dramatically increasing their reliance on aerobic glycolysis. This metabolic switch is indispensable for generating the ATP and biosynthetic precursors required for their rapid proliferation and acquisition of effector functions, enabling a robust adaptive immune response against encountered threats [6].

Pathogens have evolved intricate strategies to exploit and manipulate the metabolic pathways of host cells, thereby ensuring their own survival and replication. This manipulation can involve hijacking host metabolites, altering host enzyme activity, or interfering with host metabolic signaling to create an environment favorable for pathogen propagation. Elucidating these complex metabolic interactions between hosts and pathogens is a critical step toward devising novel anti-infective therapies that specifically target pathogen metabolic dependencies [7].

Metabolic enzymes serve as crucial regulators of inflammatory pathways, extending their roles beyond basic metabolism. Specific metabolic intermediates and enzymes can directly impact signaling cascades that drive inflammation, identifying them as promising targets for therapeutic intervention. Modulating the activity of these enzymes could offer new ways to control excessive or chronic inflammation in various disease states [8].

Autophagy, a fundamental cellular process involved in the degradation and recycling of cellular components, is intimately linked with cellular metabolism and is vital for immune cell function and survival. Its proper regulation is essential for maintaining immune homeostasis by clearing cellular waste and providing nutrients under stress. Autophagy dysfunction can compromise immune cell function and contribute to inflammatory diseases [9].

Dietary interventions can profoundly influence immunometabolism by altering nutrient availability and shaping the gut microbiome's metabolic output. This highlights the significant potential of nutritional strategies to modulate immune responses and treat metabolic and inflammatory conditions. By carefully designing diets, it may be possible to rebalance immune circuits and promote health [10].

Conclusion

Immunometabolism explores the critical interplay between immune cell function and cellular metabolism. Metabolic pathways like glycolysis and oxidative phosphorylation are reprogrammed to fuel immune responses, affecting T cell differentiation and macrophage polarization. Mitochondria are central to immune cell activation, with their dysfunction impairing immunity. The gut microbiome influences immunity through metabolites like SCFAs, crucial for immune tolerance. Cancer cells exhibit metabolic reprogramming for proliferation and immune evasion, presenting therapeutic targets. Metabolic cues regulate the balance of pro- and anti-inflammatory responses, influencing macrophage polarization. T cell differentiation is dictated by metabolic programs, with naive T cells using oxidative phosphorylation and effector T cells relying on glycolysis. Pathogens manipulate host metabolism for survival, making host-pathogen metabolic interactions key for anti-infective strategies. Metabolic enzymes regulate inflammation, serving as therapeutic targets. Autophagy is linked to metabolism and crucial for immune cell homeostasis. Dietary interventions can modulate immunometabolism, impacting immune responses and disease treatment.

References

1. David AP, Jason WB, Daisuke KS. (2021) .Nature 597:459-466.

   , ,

2. Shogo S, Masaru T, Makoto M. (2022) .Cell Metabolism 34:791-807.

   , ,

3. Lana AA, Thomas JB, Sarah MO. (2023) .Immunity 56:1713-1729.

   , ,

4. Eugenio S, Anna MR, Marco B. (2020) .Cancer Cell 38:1293-1307.

   , ,

5. Pietro DS, Giulia F, Marco L. (2021) .Journal of Experimental Medicine 218:e20201869.

   , ,

6. Elena C, Roberto R, Francesca R. (2022) .Science Immunology 7:eabf1357.

   , ,

7. Giulia DL, Lorenzo R, Marco M. (2023) .Nature Microbiology 8:1861-1873.

   , ,

8. Alessia B, Federico R, Giovanna V. (2020) .Trends in Biochemical Sciences 45:711-722.

   , ,

9. Silvia F, Andrea R, Paolo E. (2022) .Molecular Cell 82:1365-1378.

   , ,

10. Cristina G, Valerio N, Marco B. (2023) .Nature Metabolism 5:587-598.

    , ,